Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial-Reference-Cited by-同舟云学术

Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial

Published:2017-02 Issue:2 Volume:12 Page:375-382
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Welsh James W.,Seyedin Steven N.,Allen Pamela K.,Hofstetter Wayne L.,Ajani Jaffer A.,Chang Joe Y.,Gomez Daniel R.,Amini Arya,Swisher Stephen G.,Blum Mariela A.,Younes Ahmed I.,Nguyen Quynh-Nhu,Minsky Bruce D.,Erasmus Jeremy J.,Lee Jeffrey H.,Bhutani Manoop,Komaki Ritsuko U.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference11 articles.

1. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

2. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy;Minsky;J Clin Oncol,2002

3. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

4. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781;Tepper;J Clin Oncol,2008

5. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation;Welsh;Cancer,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study;CHINESE J CANCER RES;2024

2. Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma;JAMA Network Open;2023-05-17

3. Validation of esophageal cancer treatment methods from 3D-CRT, IMRT, and Rapid Arc plans using custom Python software to compare radiobiological plans to normal tissue integral dosage;Reports of Practical Oncology and Radiotherapy;2023-04-06

4. High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial;International Journal of Radiation Oncology*Biology*Physics;2023-04

5. High versus standard radiation dose of definitive concurrent chemoradiotherapy for esophageal cancer: A systematic review and meta-analysis of randomized clinical trials;Radiotherapy and Oncology;2023-03